BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain

The bromodomain protein, BRD4, has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt’s lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer. BRD4 also contributes to regulation of both cell cycle and transcription of oncogenes, HIV, and human papilloma virus (HPV). Despite its role in a broad range of biological processes, the precise molecular mechanism of BRD4 function remains unknown. We report that BRD4 is an atypical kinase that binds to the carboxyl-terminal domain (CTD) of RNA polymerase II and directly phosphorylates its serine 2 (Ser2) sites both in vitro and in vivo under conditions where other CTD kinases are inactive. Phosphorylation of the CTD Ser2 is inhibited in vivo by a BRD4 inhibitor that blocks its binding to chromatin. Our finding that BRD4 is an RNA polymerase II CTD Ser2 kinase implicates it as a regulator of eukaryotic transcription.

[1]  M. Fraga,et al.  Aberrant epigenetic regulation of bromodomain Brd4 in human colon cancer , 2012, Journal of Molecular Medicine.

[2]  S. Lowe,et al.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.

[3]  S. Robson,et al.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia , 2011, Nature.

[4]  S. Knapp,et al.  Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. , 2011, Molecular bioSystems.

[5]  P. Sandy,et al.  Targeting MYC dependence in cancer by inhibiting BET bromodomains , 2011, Proceedings of the National Academy of Sciences.

[6]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[7]  Jennifer A. Smith,et al.  The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3 , 2011, Molecular and Cellular Biology.

[8]  C. Rice,et al.  Suppression of inflammation by a synthetic histone mimic , 2010, Nature.

[9]  J. Lis,et al.  CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. , 2010, Genes & development.

[10]  S. Nishikawa,et al.  Adult Stem Cells Exhibit Global Suppression of RNA Polymerase II Serine‐2 Phosphorylation , 2010, Stem cells.

[11]  S. Buratowski.  Progression through the RNA polymerase II CTD cycle. , 2009, Molecular cell.

[12]  Shona Murphy,et al.  Cracking the RNA polymerase II CTD code. , 2008, Trends in genetics : TIG.

[13]  N. Crawford,et al.  Bromodomain 4 activation predicts breast cancer survival , 2008, Proceedings of the National Academy of Sciences.

[14]  D. Singer,et al.  TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb , 2008, Proceedings of the National Academy of Sciences.

[15]  Dirk Eick,et al.  Transcribing RNA Polymerase II Is Phosphorylated at CTD Residue Serine-7 , 2007, Science.

[16]  T. Mahmoudi,et al.  Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription , 2007, Proceedings of the National Academy of Sciences.

[17]  Shwu‐Yuan Wu,et al.  The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation* , 2007, Journal of Biological Chemistry.

[18]  H. Phatnani,et al.  Phosphorylation and functions of the RNA polymerase II CTD. , 2006, Genes & development.

[19]  B. Peterlin,et al.  Controlling the elongation phase of transcription with P-TEFb. , 2006, Molecular cell.

[20]  A. Wlodawer,et al.  The RIO kinases: an atypical protein kinase family required for ribosome biogenesis and cell cycle progression. , 2005, Biochimica et biophysica acta.

[21]  J. Brady,et al.  The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. , 2005, Molecular cell.

[22]  Qiang Zhou,et al.  Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. , 2005, Molecular cell.

[23]  S. Munir Alam,et al.  C-terminal Repeat Domain Kinase I Phosphorylates Ser2 and Ser5 of RNA Polymerase II C-terminal Domain Repeats* , 2004, Journal of Biological Chemistry.

[24]  J. Fletcher,et al.  BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. , 2003, Cancer research.

[25]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[26]  Marie W Wooten,et al.  In-Gel Kinase Assay as a Method to Identify Kinase Substrates , 2002, Science's STKE.

[27]  Jerard Hurwitz,et al.  A Mammalian Bromodomain Protein, Brd4, Interacts with Replication Factor C and Inhibits Progression to S Phase , 2002, Molecular and Cellular Biology.

[28]  R. Beddington,et al.  Growth and Early Postimplantation Defects in Mice Deficient for the Bromodomain-Containing Protein Brd4 , 2002, Molecular and Cellular Biology.

[29]  G. Prelich.  RNA Polymerase II Carboxy-Terminal Domain Kinases: Emerging Clues to Their Function , 2002, Eukaryotic Cell.

[30]  P. Sharp,et al.  Positive Transcription Elongation Factor b Phosphorylates hSPT5 and RNA Polymerase II Carboxyl-terminal Domain Independently of Cyclin-dependent Kinase-activating Kinase* , 2001, The Journal of Biological Chemistry.

[31]  E. Sausville,et al.  Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication* , 2000, The Journal of Biological Chemistry.

[32]  J. Lippincott-Schwartz,et al.  A Bromodomain Protein, MCAP, Associates with Mitotic Chromosomes and Affects G2-to-M Transition , 2000, Molecular and Cellular Biology.

[33]  R. Pestell,et al.  Cell cycle regulation and RNA polymerase II. , 2000, Frontiers in bioscience : a journal and virtual library.

[34]  T. Schulz,et al.  Latent Nuclear Antigen of Kaposi’s Sarcoma-Associated Herpesvirus Interacts with RING3, a Homolog of theDrosophila Female Sterile Homeotic (fsh) Gene , 1999, Journal of Virology.

[35]  R. Tjian,et al.  Functional analysis of the human TAFII250 N-terminal kinase domain. , 1998, Molecular cell.

[36]  M. Green,et al.  A novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulator. , 1996, Genes & development.

[37]  J. Corden,et al.  Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations. , 1995, Genetics.